SYROS PHARMACEUTICALS INC's ticker is and the CUSIP is 87184Q206. A total of 52 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 868,403 | $5,593,000 | 3.69% |
| Bain Capital Life Sciences Investors, LLC | 1,082,404 | $6,971,000 | 0.83% |
| Omega Fund Management, LLC | 251,270 | $1,618,000 | 0.59% |
| DAFNA Capital Management LLC | 265,878 | $1,712,000 | 0.46% |
| Artal Group S.A. | 1,463,829 | $9,427,000 | 0.40% |
| Flagship Pioneering Inc. | 993,848 | $6,400,000 | 0.27% |
| CVI Holdings, LLC | 425,500 | $2,740,000 | 0.21% |
| Avidity Partners Management LP | 900,000 | $5,796,000 | 0.12% |
| ACT CAPITAL MANAGEMENT, LLC | 3,499 | $23,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 721,914 | $4,649,000 | 0.01% |